Even With A 27% Surge, Cautious Investors Are Not Rewarding Lavipharm S.A.'s (ATH:LAVI) Performance Completely
Jan 28
Have your own idea? Try our Stock Screener
Greek (ASE) Healthcare Sector Analysis
UpdatedMar 01, 2026
DataAggregated Company Financials
Companies4
- 7D0.3%
- 3M27.1%
- 1Y27.7%
- YTD13.4%
The Healthcare industry has stayed flat over the last week. As for the the longer term, the industry is up 28% over the past 12 months.
Sector Valuation and Performance
Has the Greek Healthcare Sector valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Sun, 01 Mar 2026 | €403.9m | €344.8m | -€1,141,784.00 | 57.1x | -353.7x | 1.2x |
| Tue, 27 Jan 2026 | €389.6m | €344.8m | -€1,141,784.00 | 51.8x | -341.2x | 1.1x |
| Thu, 25 Dec 2025 | €344.3m | €344.8m | -€1,141,784.00 | 42.1x | -301.5x | 1x |
| Sat, 22 Nov 2025 | €308.8m | €344.4m | -€1,261,708.00 | 38.2x | -244.7x | 0.9x |
| Mon, 20 Oct 2025 | €311.1m | €344.0m | -€1,799,901.00 | 38.7x | -172.8x | 0.9x |
| Wed, 17 Sep 2025 | €352.9m | €342.0m | €11.7m | 17.4x | 30.1x | 1x |
| Fri, 15 Aug 2025 | €351.7m | €342.0m | €11.7m | 16.2x | 30x | 1x |
| Sun, 13 Jul 2025 | €307.5m | €342.0m | €11.7m | 15.9x | 26.2x | 0.9x |
| Tue, 10 Jun 2025 | €301.6m | €342.0m | €11.7m | 15.4x | 25.7x | 0.9x |
| Thu, 08 May 2025 | €302.2m | €342.3m | €11.8m | 18x | 25.6x | 0.9x |
| Sat, 05 Apr 2025 | €295.7m | €72.4m | €9.7m | 14.8x | 30.5x | 4.1x |
| Mon, 03 Mar 2025 | €316.4m | €70.8m | €8.2m | 18.9x | 38.7x | 4.5x |
| Wed, 29 Jan 2025 | €300.6m | €70.8m | €8.2m | 12.4x | 36.8x | 4.2x |
| Fri, 27 Dec 2024 | €270.7m | €320.1m | €17.2m | 13.4x | 15.7x | 0.8x |
| Sun, 24 Nov 2024 | €266.0m | €320.1m | €17.2m | 13.1x | 15.4x | 0.8x |
| Tue, 22 Oct 2024 | €275.0m | €320.1m | €17.2m | 13.3x | 16x | 0.9x |
| Thu, 19 Sep 2024 | €277.9m | €320.9m | €12.7m | 16.1x | 21.9x | 0.9x |
| Sat, 17 Aug 2024 | €290.3m | €320.9m | €12.7m | 14.9x | 22.9x | 0.9x |
| Mon, 15 Jul 2024 | €311.4m | €320.9m | €12.7m | 15.4x | 24.6x | 1x |
| Wed, 12 Jun 2024 | €300.4m | €320.9m | €12.7m | 14.7x | 23.7x | 0.9x |
| Fri, 10 May 2024 | €304.3m | €320.9m | €13.2m | 15.5x | 23x | 0.9x |
| Sun, 07 Apr 2024 | €307.6m | €320.7m | €13.0m | 16.2x | 23.7x | 1x |
| Tue, 05 Mar 2024 | €323.2m | €320.7m | €13.0m | 16.8x | 24.9x | 1x |
| Thu, 01 Feb 2024 | €327.0m | €323.7m | €11.3m | 17.7x | 29x | 1x |
| Sat, 30 Dec 2023 | €310.4m | €323.7m | €11.3m | 17.6x | 27.6x | 1x |
| Mon, 27 Nov 2023 | €289.6m | €323.7m | €11.3m | 17.1x | 25.7x | 0.9x |
| Wed, 25 Oct 2023 | €264.1m | €326.3m | €12.9m | 16.4x | 20.5x | 0.8x |
| Fri, 22 Sep 2023 | €286.4m | €305.1m | €10.1m | 22.9x | 28.5x | 0.9x |
| Sun, 20 Aug 2023 | €302.0m | €305.1m | €10.1m | 24.3x | 30x | 1x |
| Tue, 18 Jul 2023 | €194.7m | €256.2m | €9.5m | 15.7x | 20.4x | 0.8x |
| Thu, 15 Jun 2023 | €164.2m | €256.2m | €9.5m | 13.5x | 17.2x | 0.6x |
| Sat, 13 May 2023 | €140.6m | €256.3m | €13.1m | 8.7x | 10.8x | 0.5x |
| Mon, 10 Apr 2023 | €151.7m | €256.1m | €13.2m | 9.3x | 11.5x | 0.6x |
| Wed, 08 Mar 2023 | €158.4m | €256.1m | €13.2m | 9.6x | 12x | 0.6x |
Price to Earnings Ratio
12x
Current Industry PE
- Investors are relatively neutral on the Greek Healthcare industry at the moment, indicating that they anticipate long term growth rates to remain steady.
- The industry is trading close to its 3-year average PS ratio of 1.3x.
Past Earnings Growth
- Total earnings for the Healthcare industry have declined over the last three years, with the industry now making a loss overall.
- Meanwhile revenues have grown 10% per year.
- This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased, which has decreased profits.
Industry Trends
Which industries have driven the changes within the Greek Healthcare sector?
| GR Market | -0.16% | |
| Healthcare | 0.32% | |
| Pharma | 1.69% | |
| Healthtech | 1.25% | |
| Medical Equipment | 0.81% | |
| Healthcare Services | -1.58% | |
Industry PE
- Investors are most optimistic about the Pharma industry, which is trading close to its 3-year average PE ratio of 117x.
- It looks like they are confident that earnings will grow faster in the future than they have historically.
Forecasted GrowthThere is insufficient data on the sub-industries of this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| LAVI Lavipharm | €1.33 | 1.7% +€3.7m | 66.4% | PE108.2x | |
| MEDIC Medicon Hellas | €2.50 | 0.8% +€88.4k | 11.6% | PE6x | |
| VIDAVO Vidavo | €8.10 | 1.3% +€85.7k | 84.1% | PS24.4x |